May hemocytometer parameters be a biomarker in distinguishing between adrenal adenomas and carcinomas and in prognosis of adrenocortical carcinomas? Mogu li hemocitometrijski parametri poslužiti kao biološki biljezi u razlikovanju adrenalnih adenoma i karcinoma te u prognozi adrenokortikalnih karcinoma?


Sisman P., Bicer B., Gul O. O. , CANDER S. , ERSOY C. , SARAYDAROĞLU Ö. , ...More

Acta Clinica Croatica, vol.59, no.3, pp.439-444, 2020 (Journal Indexed in SCI) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 59 Issue: 3
  • Publication Date: 2020
  • Doi Number: 10.20471/acc.2020.59.03.07
  • Title of Journal : Acta Clinica Croatica
  • Page Numbers: pp.439-444
  • Keywords: Adrenal adenoma, Adrenocortical carcinoma, Hemocytometer parameters, Mean platelet volume, Neutrophil to lymphocyte ratio, NEUTROPHIL-TO-LYMPHOCYTE, MANAGEMENT, CANCER

Abstract

© 2020, Dr. Mladen Stojanovic University Hospital. All rights reserved.Recently, studies have reported that inflammatory response and elevated platelet counts are associated with several cancers. In the present study, we aimed to evaluate hemocytometer parameters in differentiating adrenal adenoma and carcinoma, and the prognostic utility of hemocy-tometer parameters in adrenocortical carcinoma (ACC). We included 30 patients with nonfunctional adrenal adenoma and 13 patients with ACC having undergone surgery between 2005 and 2017 and followed up postoperatively at our centre. The neutrophil/lymphocyte ratio (NLR), platelet/lympho-cyte ratio (PLR), red blood cell distribution width (RDW), mean platelet volume (MPV) and platelet-crit (PCT) were evaluated preoperatively in all patients included in the study. There was a significant difference between the adrenal adenoma and ACC groups in terms of neutrophil and lymphocyte counts, NLR and PLR. There was no significant difference between the two groups in terms of platelet count and MPV, but PCT levels were significantly lower in ACC group. There was no statistically significant difference between recurrent and/or metastasis positive patients and negative ones according to NLR, PLR, RDW and MPV. There was a statistically significant difference in RDW levels and tumor diameter between the groups. Our study is the first to evaluate hemocytometer parameters in differentiating adrenal adenomas and carcinomas, and also in the prognosis of ACC.The present study suggested that the hemocytometer parameters may be a marker in the differential diagnosis of adrenal adenomas and carcinomas. However, our study also showed that these parameters had no prognostic value in ACC.